Aster DM Healthcare Limited
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare services in India. It operates through Hospitals, Clinics, Wholesale Pharmacies, and Others segments. The company operates hospitals, clinic, and in-house pharmacies at the hospitals and clinics. It also offers healthcare consultancy and other services. In addition, the company operates retail pharmacies and optical outlets. Aster DM Healthcare Limited was founded in 1987 and is based in Bengaluru, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Strong 5-year revenue CAGR of 21.8%
Concerns1
- Low return on equity of 5.4%
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ2.32 K Cr | β | βΉ6.21 K Cr | β | β | 209.3% | 13.9% | 3854.8% |
| Mar 2024 | βΉ2.04 K Cr | β | βΉ157.00 Cr | β | β | 5.4% | 32.7% | -9.2% |
| Mar 2023 | βΉ1.53 K Cr | β | βΉ173.00 Cr | β | β | 6.3% | 37.5% | 92.2% |
| Mar 2022 | βΉ1.12 K Cr | β | βΉ90.00 Cr | β | β | 3.5% | 49.4% | -230.4% |
| Mar 2021 | βΉ747.00 Cr | β | βΉ-69.00 | β | β | -2.4% | -1.7% | -213.1% |
| Mar 2020 | βΉ760.00 Cr | β | βΉ61.00 Cr | β | β | 2.1% | 27.7% | 27.1% |
| Mar 2019 | βΉ595.00 Cr | β | βΉ48.00 Cr | β | β | 1.6% | 12.3% | -155.2% |
| Mar 2018 | βΉ530.00 Cr | β | βΉ-87.00 | β | β | -3.0% | 39.5% | -285.1% |
| Mar 2017 | βΉ380.00 Cr | β | βΉ47.00 Cr | β | β | 2.0% | 101.1% | -127.6% |
| Mar 2016 | βΉ189.00 Cr | β | βΉ-170.00 | β | β | -18.1% | 256.6% | 117.9% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 2,445 |
| Total Expenses | 1,936 |
| EBIT / Operating Profit | 509 |
| OPM % | 21% |
| Other Income | 101 |
| Finance Costs | 89 |
| Depreciation & Amortisation | 150 |
| Profit Before Tax | 371 |
| Tax % | - |
| Net Profit / PAT | 296 |
| EPS (βΉ) | 5.80 |
| Dividend Payout % | - |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Aster DM Healthcare Limitedthis co. | βΉ31.36 K Cr | βΉ2.32 K Cr | 92.80 | 7.08 | 78.20 | 13.9% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |